IGF1 and neoplasm: Thus, losartan exerts multicompartmental effects, simultaneously acting on the vasculature (improved perfusion), immune compartment (enhanced immune infiltration and activation), and tumor cells (attenuated IGF-1 signaling), while indirectly reshaping CSC-supportive niches through ECM normalization.